Table 3.
Treatment | Replicate 1 | Replicate 2 | Replicate 3 |
---|---|---|---|
Amp | 161.08 ± 57.98* | 163.06 ± 21.78* | 157.23 ± 36.36* |
Amp + Sul | 176.22 ± 42.31* | 165.27 ± 18.78* | 173.34 ± 50.24* |
Tolt | 149.34 ± 35.11 ns | 167.94 ± 55.75 ns | 142.51 ± 50.51 ns |
NegCntr | 185.56 ± 9.75* | 182.43 ± 10.43* | 183.00 ± 17.85* |
PosCntr | 112.27 ± 39.95 | 140.41 ± 21.35 | 131.02 ± 45.10 |
Tolt, toltrazuril; Amp, amprolium hydrochloride; Amp + Sul: Amprolium hydrochloride + sulfaquinoxaline sodium; NegCntr: uninfected-unmedicated negative control; PosCntr: infected-unmedicated positive control. Data represent mean ± SD (∗: P < 0.05 vs. PosCntr; ns: no significant differences).